Cardiomyopathy Tissue Bank in a Cancer Population

• Conditions: Heart Disease
• Interventions: Procedure: Blood Sample

• Registration Number: NCT00500734
• Lead Sponsor: M.D. Anderson Cancer Center

Brief Summary

Any time the words "you," "your," "I," or "me" appear, it is meant to apply to the potential participant.

The goal of this laboratory research study is to collect and store blood and tissue from patients who have a diagnosis of heart disease and may be at a high risk for the development of heart failure. This blood may be used in the future to identify genes that may play a role in developing congestive heart failure (CHF) from chemotherapy or other sources.

This is an investigational study. All will be enrolled at MD Anderson.

Detailed Description

You will have a one time blood draw of 2 teaspoons of blood for use in future research. This blood may be studied in the future to try to find possible genetic or biochemical markers that may be the cause of CHF. Your blood will be drawn either on an outpatient basis or during a routine visit to the hospital. If you already have a central line or an IV placed, the blood will be drawn at these sites to decrease the pain and discomfort of the blood draw. The information obtained in this study will not be put into your medical records.

Study Timeline

• Study Start: 2002-12-10
• Study First Submitted: 2007-07-12
• Study First Submitted QC: 2007-07-12
• Study First Posted: 2007-07-13
• Status Verified: 2020-01
• Last Update Submitted: 2020-01-24
• Last Update Posted: 2020-01-27
• Primary Completion: 2020-12
• Study Completion: 2020-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 1000

Inclusion Criteria

• Patients who are at high risk for developing Cardiomyopathy or Congestive Heart Failure.
• Patients two months of age and older.

Read More

Exclusion Criteria

• Those that are not willing to sign an informed consent.

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Heart Disease Patients	Blood Sample	-

Primary Outcome Measures

Name	Time	Method
Identification biological markers predisposing cancer patients to development of chemotherapy-induced congestive heart failure	One time visit for collection of blood and tissue samples.
Baseline Patient Demographic Information (age, sex, race)	One time visit.

Trial Locations

Locations (1)

University of Texas MD Anderson Cancer Center; 🇺🇸 Houston, Texas, United States